JP2024515062A5 - - Google Patents
Info
- Publication number
- JP2024515062A5 JP2024515062A5 JP2023561906A JP2023561906A JP2024515062A5 JP 2024515062 A5 JP2024515062 A5 JP 2024515062A5 JP 2023561906 A JP2023561906 A JP 2023561906A JP 2023561906 A JP2023561906 A JP 2023561906A JP 2024515062 A5 JP2024515062 A5 JP 2024515062A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21167690 | 2021-04-09 | ||
| EP21167690.3 | 2021-04-09 | ||
| EP21181134 | 2021-06-23 | ||
| EP21181134.4 | 2021-06-23 | ||
| PCT/EP2022/059527 WO2022214691A1 (en) | 2021-04-09 | 2022-04-08 | Deuterated dhodh inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515062A JP2024515062A (ja) | 2024-04-04 |
| JPWO2022214691A5 JPWO2022214691A5 (https=) | 2025-04-15 |
| JP2024515062A5 true JP2024515062A5 (https=) | 2025-04-15 |
Family
ID=81585846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561906A Pending JP2024515062A (ja) | 2021-04-09 | 2022-04-08 | 重水素化ｄｈｏｄｈ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240199535A1 (https=) |
| EP (1) | EP4320100A1 (https=) |
| JP (1) | JP2024515062A (https=) |
| KR (1) | KR20240007144A (https=) |
| AU (1) | AU2022253683A1 (https=) |
| BR (1) | BR112023020806A2 (https=) |
| CA (1) | CA3215002A1 (https=) |
| IL (1) | IL307559A (https=) |
| MX (1) | MX2023011864A (https=) |
| WO (1) | WO2022214691A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3139914T3 (pl) | 2014-05-08 | 2023-11-27 | Kiora Pharmaceuticals Gmbh | Związki stosowane w leczeniu chorób i schorzeń okulistycznych |
| ES2972099T3 (es) | 2018-03-09 | 2024-06-11 | Kiora Pharmaceuticals Gmbh | Formulación oftálmica |
| WO2023172818A1 (en) * | 2022-03-09 | 2023-09-14 | Kiora Pharmaceuticals Gmbh | Polymorphs of a dihydroorotate dehydrogenase (dhod) inhibitor |
| TW202444688A (zh) | 2023-03-29 | 2024-11-16 | 德商埃慕尼克股份公司 | 作為nurr1激動劑之維多氟地莫(vidofludimus)及相關結構 |
| TW202506107A (zh) | 2023-06-28 | 2025-02-16 | 德商埃慕尼克股份公司 | 雜芳族dhodh抑制劑 |
| WO2025215126A1 (en) | 2024-04-12 | 2025-10-16 | Immunic Ag | Synthesis of vidofludimus and its calcium salt |
| WO2026074007A1 (en) | 2024-10-02 | 2026-04-09 | Immunic Ag | Nurr1 agonists with replacement of the carboxylic acid or carboxamide moiety for use in the treatment of neurodegenerative diseases |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04000224A (es) * | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
| US7071355B2 (en) | 2002-12-23 | 2006-07-04 | 4 Sc Ag | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| EP1581478A1 (en) | 2002-12-23 | 2005-10-05 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| MXPA05006890A (es) | 2002-12-23 | 2006-04-07 | 4Sc Ag | Compuestos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. |
| DK2050749T3 (en) | 2006-08-08 | 2018-01-08 | Chugai Pharmaceutical Co Ltd | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF |
| WO2009140279A2 (en) | 2008-05-12 | 2009-11-19 | Concert Pharmaceuticals, Inc. | Sulfonyl urea compounds |
| CN102271674A (zh) | 2008-11-07 | 2011-12-07 | 4Sc股份公司 | 用于治疗自身免疫病的包含dhodh抑制剂和氨甲喋呤的联合治疗 |
| TWI530286B (zh) | 2009-05-04 | 2016-04-21 | 帕納特斯製藥格斯有限公司 | 作為抑制病毒化合物之抗發炎劑 |
| UA108760C2 (uk) | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
| KR102265277B1 (ko) * | 2014-04-11 | 2021-06-16 | 판옵테스 파르마 게스.엠.베.하. | 바이러스 억제 화합물로서의 항-염증제 |
| PL3139914T3 (pl) | 2014-05-08 | 2023-11-27 | Kiora Pharmaceuticals Gmbh | Związki stosowane w leczeniu chorób i schorzeń okulistycznych |
| WO2016045587A1 (zh) | 2014-09-26 | 2016-03-31 | 常州寅盛药业有限公司 | 作为ns4b抑制剂的苯并呋喃类似物 |
| CN108430998B (zh) | 2016-09-28 | 2021-07-09 | 四川科伦博泰生物医药股份有限公司 | 氮杂双环衍生物及其制备方法和用途 |
| WO2018177151A1 (en) * | 2017-03-28 | 2018-10-04 | Xiamen University | Compounds modulating activity of farnesoid x receptor and methods for the use thereof |
| CN111343975A (zh) | 2017-11-23 | 2020-06-26 | 埃慕尼克股份公司 | 用于预防或治疗慢性炎性疾病和/或自身免疫疾病的维多地莫的剂量方案 |
| JP6804790B1 (ja) | 2017-12-07 | 2020-12-23 | エモリー ユニバーシティー | Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 |
| ES2972099T3 (es) | 2018-03-09 | 2024-06-11 | Kiora Pharmaceuticals Gmbh | Formulación oftálmica |
| WO2019175396A1 (en) | 2018-03-16 | 2019-09-19 | Immunic Ag | Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
-
2022
- 2022-04-08 MX MX2023011864A patent/MX2023011864A/es unknown
- 2022-04-08 KR KR1020237038184A patent/KR20240007144A/ko active Pending
- 2022-04-08 IL IL307559A patent/IL307559A/en unknown
- 2022-04-08 JP JP2023561906A patent/JP2024515062A/ja active Pending
- 2022-04-08 WO PCT/EP2022/059527 patent/WO2022214691A1/en not_active Ceased
- 2022-04-08 BR BR112023020806A patent/BR112023020806A2/pt unknown
- 2022-04-08 US US18/554,365 patent/US20240199535A1/en active Pending
- 2022-04-08 AU AU2022253683A patent/AU2022253683A1/en active Pending
- 2022-04-08 EP EP22721769.2A patent/EP4320100A1/en active Pending
- 2022-04-08 CA CA3215002A patent/CA3215002A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024515062A5 (https=) | ||
| CL2025003816A1 (es) | Trituradora de rodillos y un método para operar la misma | |
| CL2025004057A1 (es) | Intermedio inhibidor de dpp1, y método de preparación para el mismo y uso del mismo en medicamentos. | |
| CL2025004011A1 (es) | Procedimiento de determinación de ubicación de un detonador en una red inalámbrica de detonadores electrónicos. | |
| CN307047755S (https=) | ||
| CN307047178S (https=) | ||
| CN307049877S (https=) | ||
| CN307049821S (https=) | ||
| CN307049581S (https=) | ||
| CN307047951S (https=) | ||
| BY13144U (https=) | ||
| CN307047540S (https=) | ||
| CN307046859S (https=) | ||
| CN307046313S (https=) | ||
| CN307045179S (https=) | ||
| CN307044758S (https=) | ||
| CN307044259S (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY13172U (https=) | ||
| BY13170U (https=) | ||
| BY13169U (https=) | ||
| BY13168U (https=) |